| CAP | CAP score (per 1.0-point increase) | PAD | ABPI (per 0.1-point increase) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
variables | Â | No. of patients | No. of AVC | OR | 95% CI | P for interaction | OR | 95% CI | P for interaction | OR | 95% CI | P for interaction | OR | 95% CI | P for interaction |
Age (years) | L (< 69.8) | 375 | 44 | 16.79 | a2.07–136.4 | 0.23 | 1.02 | 0.94–1.12 | 0.16 | 2.72 | 0.91–8.15 | 0.91 | 0.90 | 0.67–1.20 | 0.17 |
H (> 69.8) | 374 | 157 | 1.94 | 0.70–5.37 | 1.09 | a1.03–1.15 | 1.84 | b1.07–3.15 | 0.78 | a0.66–0.92 | |||||
Sex | Male | 499 | 142 | 3.55 | b1.00–12.52 | 0.96 | 1.07 | a1.02–1.13 | 0.82 | 2.04 | b1.17–3.54 | 0.58 | 0.79 | a0.67–0.93 | 0.49 |
Female | 250 | 59 | 3.12 | 0.93–10.39 | 1.06 | 0.97–1.17 | 1.04 | 0.36–3.01 | 0.96 | 0.70–1.30 | |||||
eGFR (mL/min/1.73m2) | L (< 28.0) | 375 | 126 | 1.26 | 0.43–3.72 | 0.06 | 1.06 | b1.00–1.12 | 0.40 | 1.62 | 0.90–2.93 | 0.049 | 0.78 | a0.65–0.92 | 0.73 |
H (> 28.0) | 374 | 75 | 7.76 | a1.70–35.47 | 1.08 | 0.999–1.17 | 1.94 | 0.78–4.77 | 0.91 | 0.69–1.20 | |||||
DM | Absence | 466 | 109 | 4.91 | a1.57–15.34 | 0.11 | 1.10 | a1.03–1.17 | 0.09 | 2.17 | b1.03–4.58 | 0.48 | 0.74 | b0.58–0.94 | 0.27 |
Presence | 283 | 92 | 1.31 | 0.32–5.44 | 1.03 | 0.96–1.11 | 1.41 | 0.72–2.76 | 0.89 | 0.74–1.07 | |||||
S-Alb (g/L) | L (≤34) | 383 | 128 | 4.71 | b1.27–17.47 | 0.13 | 1.06 | b1.00–1.12 | 0.21 | 2.45 | a1.30–4.60 | 0.08 | 0.81 | b0.67–0.97 | 0.62 |
H (> 34) | 366 | 73 | 1.54 | 0.46–5.24 | 1.12 | b1.02–1.22 | 1.04 | 0.44–2.48 | 0.85 | 0.65–1.12 |